Overview
Clinical Research of TCM on Pelvic Inflammatory Disease Sequelae
Status:
Unknown status
Unknown status
Trial end date:
2018-12-01
2018-12-01
Target enrollment:
0
0
Participant gender:
Female
Female
Summary
The trial attempts to optimize, standardize and simplify the characteristic diagnosis and treatment program of the dominant diseases in our hospital-the sequelae of pelvic inflammatory disease, so as to make it suitable for clinical diagnosis and treatment in primary hospital.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Shanghai University of Traditional Chinese Medicine
Criteria
Inclusion Criteria:1. Patients with diagnostic criteria for the sequelae of pelvic inflammatory disease in
Western medicine;
2. Patients conforming to the criteria of TCM syndrome differentiation;
3. Age 18--60 years old, married or sexual life;
4. In this study, the voluntary participation, and signed informed consent;
Exclusion Criteria:
1. Patients who do not meet the diagnostic criteria of Western medicine and traditional
Chinese medicine dialectical typing standard;
2. Persons with acute pelvic inflammatory disease;
3. Related symptoms caused by diseasesGynecological tumor,specific vaginitis, acute
cervicitis, pelvic congestion syndrome, endometriosis, adenomyosis, pelvic
tuberculosis etc.
4. Pregnant and lactating women;
5. With severe primary disease, such as liver, kidney, heart, brain and hematopoietic
system;
6. Allergic to a variety of drugs or known to be allergic to the composition of the use
of traditional Chinese Medicine;
7. Patients taking part in other clinical trials;
8. Suspect or do have a history of alcohol, drug abuse or according to the judgment of
the researcher,other lesions or circumstances that have reduced the likelihood of
entering a group or the complexity of entering a group,such as frequent changes in the
working environment, the living environment is not stable,etc.